Objectives: The aim of this study was to characterize fluoroquinolone-resistant Shigella and determine whether the qnr and aac(6 0 )-Ib-cr genes could contribute to sporadic shigellosis at the clinic in the Hangzhou area of China.
Introduction
Diarrhoea caused by Shigella species is a major public health problem in developing countries because many cases are caused by drug-resistant Shigella.
1,2 Cases infected with fluoroquinoloneresistant Shigella have been reported in some areas of China, but not in Hangzhou. 1 Fluoroquinolone resistance is mainly mediated by mutations in the genes encoding DNA gyrase and topoisomerase IV, i.e. the gyrA, gyrB, parC and parE genes, in the quinolone resistance-determining regions (QRDRs). 3 It is also caused by the plasmid-borne genes qnrA, qnrB and qnrS in many strains of Enterobacteriaceae, including Shigella, worldwide. 4 -7 However, since the qnrS gene was first identified in isolates of Shigella flexneri 2b in Japan in 2005, 8 no new case related to Shigella has been reported worldwide. The aac(6 0 )-Ib-cr gene is carried by a plasmid, leading to transferable fluoroquinolone resistance in Enterobacteriaceae, 9 and was recently identified in isolates of Shigella boydii serotype 1 and S. flexneri 3b. 2 However, aac(6 0 )-Ib-cr-mediated fluoroquinolone resistance in Shigella has not been reported in China. Here, we present novel strains of fluoroquinolone-resistant Shigella from the Hangzhou area of China. 
Materials and methods

Bacterial strains
Antimicrobial susceptibility testing
Antimicrobial susceptibility was determined by the disc diffusion method, in accordance with CLSI (formerly NCCLS) guidelines (M7-A5) for nalidixic acid (30 mg disc), ciprofloxacin (5 mg disc) and levofloxacin (10 mg disc). Escherichia coli ATCC 25922 was used for quality control.
Isolation of plasmids
The plasmids from fluoroquinolone-resistant strains were extracted using the plasmid Miniprep kit (QIAGEN), according to the manufacturer's instructions. Plasmid profiles were characterized by electrophoresis using a 1% agarose gel.
Analysis of mutations in the QRDRs
A total of 15 strains of fluoroquinolone-resistant S. flexneri, together with 8 strains of S. flexneri that were susceptible to fluoroquinolones (ciprofloxacin and levofloxacin), 4 susceptible to nalidixic acid and the other 4 resistant, were grown in Luria-Bertani (LB) medium. Their genomic DNA was extracted and used as a template. The mutations of the gyrA, gyrB, parC and parE genes in the QRDRs were analysed by PCR and sequencing as reported previously. 3 Characterization of the qnr and aac(6 0 )-Ib-cr genes
The qnrA, qnrB and qnrS genes were characterized by multiplex PCR. 6 The sequences of the primers specific for the qnrS gene were forward 5 0 -TGGAAACCTACAATCATACATATCG-3 0 and reverse 5 0 -TTAGTCAGGATAAACAACAATACCC-3 0 , which produced a 656 bp fragment. The primers for the aac(6 0 )-Ib-cr gene were forward 5 0 -GCAACGCAAAAACAAAGTTAGG-3 0 and reverse 5 0 -GTGTTTGAACCATGTACA-3 0 , which generated a 560 bp product. All positive PCR products were further sequenced.
PCR-based plasmid replicon typing
The incompatibility of plasmids involved in drug resistance was analysed by a PCR-based plasmid replicon typing assay, as described previously. 10 
PFGE
The chromosomal DNA fingerprints for some selected isolates were analysed by PFGE after digestion with XbaI (Takara), followed by gel electrophoresis at 6 V/cm for 18 h, with conditions generated by the autoalgorithm mode from the CHEF Q system (Bio-Rad). Their similarities were analysed by cluster analysis using Diversity Database fingerprinting software (Bio-Rad).
Results
Prevalence of fluoroquinolone-resistant Shigella species
All S. sonnei strains were susceptible, but 15 out of 123 S. flexneri showed different levels of resistance to nalidixic acid, ciprofloxacin and levofloxacin. These fluoroquinolone-resistant strains were isolated from 1998 to 2007, except in 1999 and 2003 (Table 1 ) and the positive rates of fluoroquinolone-resistant isolates varied between 8.3% and 20.0%. The time distribution and the frequency of fluoroquinolone-resistant isolates did not show a special pattern, suggesting that these strains of fluoroquinolone-resistant S. flexneri have existed for a while in this area and remain active in human infection.
Fluoroquinolone-resistant S. flexneri isolates carried common mutations in the QRDRs
There was no single strain of fluoroquinolone-resistant S. flexneri that displayed mutations in the gyrB and parE genes, although 15 strains of S. flexneri displayed two identical mutations in the gyrA and parC genes ( Table 1) . The mutations at codon 83 (TCG!TTG) in the gyrA gene and at codon 80 (AGC!ATC transversion) in the parC gene resulted in the replacement of serine by leucine and isoleucine, respectively. Furthermore, 10 out of 15 fluoroquinolone-resistant isolates showed an additional mutation at gyrA codon 87 (GAC!AAC, GGC or GTC transition/transversion), resulting in the replacement of aspartic acid by asparagine, glycine or valine, respectively.
Characterization of qnr and aac(6 0 )-Ib-cr genes
Five out of 15 fluoroquinolone-resistant isolates contained the qnrS gene and their serotypes were S. flexneri 1a, 2a and 4c (Table 1 ). Further analysis revealed that their sequences were identical to that of pAH0376 from a strain of S. flexneri 2b. 3 In addition, 2 (one S. flexneri 2a and one S. flexneri 4c) out of 15 isolates were positive for the aac(6 0 )-Ib-cr gene (Table 1) .
PCR-based plasmid replicon typing
All fluoroquinolone-resistant isolates carried the IncF and IncK replicons. Furthermore, isolate 4 contained the IncFIA replicon while isolates 14 and 15 had the I1-Ir incompatibility group replicon (Table 1) . Therefore, the plasmids carried by the majority of the 15 isolates were incompatible.
PFGE and plasmid analysis
The DNA fingerprinting of 15 isolates showed eight distinct XbaI restriction patterns by PFGE and the similarity among them was from 75% to 92%, determined by Dice's coefficient analysis (data not shown). Interestingly, two isolates (11 and 12) that were negative for qnr and aac(6 0 )-Ib-cr were identical, which was similar to isolate 13 carrying both the qnr and aac(6 0 )-Ib-cr genes. Furthermore, the profiles of plasmids from the fluoroquinolone-resistant isolates showed no association with the presence of the qnrS and aac(6 0 )-Ib-cr genes (Figure 1 ). Thus, it is unlikely that those strains of fluoroquinolone-resistant S. flexneri originated from a progenitor. 
Discussion
We found that no isolate of S. sonnei showed fluoroquinolone resistance while 15 strains of S. flexneri had different levels of resistance to fluoroquinolones. The percentage of fluoroquinolone-resistant S. flexneri was similar to that in other areas of China. 1 Notably, one strain of fluoroquinolone-resistant S. flexneri 2a was isolated from the Hangzhou area in 1998. However, the incidence of shigellosis with fluoroquinoloneresistant S. flexneri in this area remains at a stable level, which differs from a report from India. 8 The low incidence may be caused by the changes in socioeconomic conditions and education in this area during the past 10 years. This also suggests that fluoroquinolone antibiotics may still be effective for many incidences of shigelloses in this area.
Genetic characterization of fluoroquinolone resistance revealed that all strains of quinolone-resistant S. flexneri had mutations at position 83 of gyrA and at position 80 of parC of the QRDRs, similar to that in isolates from other areas. 3 These mutations are responsible for mediating quinolone resistance. Notably, these 15 strains of S. flexneri either showed mutation at position 87 of gyrA or carried the qnrS gene. 8 However, four strains of S. flexneri that were resistant to nalidixic acid, but susceptible to ciprofloxacin and levofloxacin, displayed neither the mutation at position 87 (Asp) of the gyrA gene nor the qnrS gene.
Interestingly, the qnrS gene was first detected in a S. flexneri serotype 1a isolate in 2002, earlier than the first report 8 in Japan in 2005. Importantly, the qnrS-positive strains of S. flexneri showed high-level resistance to fluoroquinolones. Therefore, the plasmid-mediated qnrS gene may have been present in different serotypes of S. flexneri in China for a while. To our knowledge, this is not only the first report of S. flexneri serotypes 1a, 2a and 4c carrying the qnrS gene, but also the first report of qnr-positive Shigella isolated from China.
The aac(6 0 )-Ib-cr gene was recently identified in many Enterobacteriaceae and is responsible for high-level resistance to fluoroquinolones. 4, 9 We found that two strains of S. flexneri (serotypes 2a and 4c) carried the aac(6 0 )-Ib-cr gene and expressed high levels of fluoroquinolone resistance, particularly to ciprofloxacin. This is the first report of aac(6 0 )-Ib-cr-positive S. flexneri 2a and 4c worldwide. The aac(6 0 )-Ib-cr-positive S. flexneri 2a was isolated in 1998, suggesting that the aac(6 0 )-Ib-cr gene had been present in China for many years. Interestingly, we found that isolate 13 carried both the qnrS and aac(6 0 )-Ib-cr genes and had high-level resistance to fluoroquinolones, similar to E. coli isolates that carry the aac(6 0 )-Ib-cr and qnrA genes. 9 Therefore, surveillance for plasmid-mediated fluoroquinolone resistance genes may be an ideal strategy for the effective control of shigellosis. Individual strains of S. flexneri isolates were grown in LB medium and their plasmids were extracted, followed by electrophoresis. Isolates 1-4, f2a; isolates 5 -7, 1a; isolate 8, f2a; isolates 9 and 10, 1a; isolate 11, f4c; isolate 12, f2a; isolate 13, f4c; isolates 14 and 15, f2a. Data shown are representative of three independent experiments.
